1. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer
   Hongzhi Zhang et al, 2019, International Journal of Biological Macromolecules CrossRef
2. Development of a 15-gene signature for predicting prognosis in advanced colorectal cancer
   Xiao Wang et al, 2020, Bioengineered CrossRef
3. RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer
   Daisuke Fujimoto et al, 2018, Oncotarget CrossRef
4. Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction
   Changyu Li et al, 2020, Mol Med CrossRef
5. Association Between rs12037447, rs146732504, rs151078858, rs55723436, and rs6094136 Polymorphisms and Kawasaki Disease in the Population of Polish Children
   Piotr Buda et al, 2021, Front. Pediatr. CrossRef
6. RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway
   Chenglin Han et al, 2021, OTT CrossRef
7. Identification and validation of a signature based on macrophage cell marker genes to predict recurrent miscarriage by integrated analysis of single-cell and bulk RNA-sequencing
   Peiru Wei et al, 2022, Front. Immunol. CrossRef
8. RPN2 in cancer: An overview
   Zhengxuan Han et al, 2023, Gene CrossRef
9. Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma
   Valentina Mari et al, 2023, Dig Dis CrossRef
10. Leu promotes C2C12 cell differentiation by regulating the GSK3β/β‐catenin signaling pathway through facilitating the interaction between SESN2 and RPN2
    Yifan Liu et al, 2024, J Sci Food Agric CrossRef